Literature DB >> 19710935

Mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis.

Hélène Massé1, Jean-Laurent Guyomard, Dominique Baudet, Jean-François Pinel, Gilles Edan, Jean-François Charlin.   

Abstract

Purpose. To report favorable outcome of a case of acute posterior multifocal placoid pigment epitheliopathy (APMPPE) associated with cerebral vasculitis after treatment with immunosuppressive therapy by mitoxantrone. Design. Single case report. Method. A 22-year-old man presented with acute isolated bilateral loss of vision revealing APMPPE. Corticosteroid therapy was initiated and visual acuity gradually improved. Seventeen days later, visual function deteriorated again, associated with flu-like syndrome and severe headaches. A relapse of APMPPE was diagnosed, complicated with lymphocytic meningitis and cerebral ischemia. Intravenous therapy with mitoxantrone was performed in combination with methylprednisolone. Results. Headaches disappeared in a few days whereas visual acuity gradually improved and stabilized at 20/40 in the right eye and 20/32 in the left eye. No adverse event was observed. Clinical improvement was confirmed by magnetic resonance imaging. Conclusion. Cerebral vasculitis is the most severe complication of the extraocular manifestations of APMPEE. This diagnosis should be evoked when severe headaches or behavior disorder are associated with APMPEE.

Entities:  

Year:  2009        PMID: 19710935      PMCID: PMC2729475          DOI: 10.1155/2009/481512

Source DB:  PubMed          Journal:  Case Rep Med


  6 in total

1.  Acute posterior multifocal placoid pigment epitheliopathy associated with a systemic necrotizing vasculitis.

Authors:  Cynthia T Hsu; Joseph B Harlan; Morton F Goldberg; James P Dunn
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

Review 2.  Management of worsening multiple sclerosis with mitoxantrone: a review.

Authors:  Edward J Fox
Journal:  Clin Ther       Date:  2006-04       Impact factor: 3.393

Review 3.  Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature.

Authors:  H S O'Halloran; J R Berger; W B Lee; D M Robertson; J A Giovannini; G B Krohel; R J Meckler; J B Selhorst; A G Lee; D A Nicolle; J O'Day
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

4.  Acute posterior multifocal placoid pigment epitheliopathy.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1968-08

Review 5.  Mitoxantrone for multiple sclerosis in clinical practice.

Authors:  Syed A Rizvi; Howard Zwibel; Edward J Fox
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

6.  Choroidal vasculitis in acute posterior multifocal placoid pigment epitheliopathy.

Authors:  R F Spaide; L A Yannuzzi; J Slakter
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

  6 in total
  2 in total

1.  Recurring meningoencephalitis in sinusitis-associated acute posterior multifocal placoid pigment epitheliopathy under prednisone tapering.

Authors:  H Joswig; C Flueckiger; A Infanger; B Tettenborn; A Felbecker
Journal:  BMJ Case Rep       Date:  2011-05-10

2.  Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE).

Authors:  Bettina C Thomas; Christian Jacobi; Mirjam Korporal; Matthias D Becker; Brigitte Wildemann; Friederike Mackensen
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.